UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2874-2880

2010

Link zum Volltext

Verfügbarkeit prüfen

Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma : N33 and EFA6R have a potential impact on overall survival

Cancer, 2005-12, Vol.104 (11), p.2417-2429

2005

Link zum Volltext

Verfügbarkeit prüfen

Fatal events during clinical trials: an evaluation of deaths during breast cancer studies

Breast cancer (Tokyo, Japan), 2019-11, Vol.26 (6), p.826-834

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

ESMO open, 2020-01, Vol.5 (6), p.e000979-e000979, Article e000979

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients

Breast care (Basel, Switzerland), 2016-02, Vol.11 (1), p.8-12

Möbus, Volker

2016

Link zum Volltext

Verfügbarkeit prüfen

Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study

European journal of cancer (1990), 2019-06, Vol.114, p.76-88

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e23098-e23098

2019

Link zum Volltext

Verfügbarkeit prüfen

Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?

Molecular cancer, 2016-02, Vol.15 (13), p.13-13, Article 13

2016

Link zum Volltext

Verfügbarkeit prüfen

mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease

International journal of cancer, 2022-04, Vol.150 (8), p.1357-1372

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase III postneoadjuvant study evaluating sacituzumab govitecan, an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS602-TPS602

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy

European journal of cancer (1990), 2021-03, Vol.145, p.44-52

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD3-04: Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD3-04-PD3-04

2021

Link zum Volltext

Verfügbarkeit prüfen

Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database

European journal of cancer (1990), 2012-09, Vol.48 (13), p.1947-1956

2012

Link zum Volltext

Verfügbarkeit prüfen

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

European journal of cancer (1990), 2023-03, Vol.181, p.92-101

2023

Link zum Volltext

Verfügbarkeit prüfen

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3531-3539

2013

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

Breast care (Basel, Switzerland), 2019-08, Vol.14 (4), p.224-245

2019

Link zum Volltext

Verfügbarkeit prüfen

A matrix of morphology and distribution of calcifications in the breast: Analysis of 849 vacuum-assisted biopsies

European journal of radiology, 2017-01, Vol.86, p.221-226

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer

Geburtshilfe und Frauenheilkunde, 2017-10, Vol.77 (10), p.1079-1087

2017

Link zum Volltext

Verfügbarkeit prüfen

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer

Acta oncologica, 2020-01, Vol.59 (1), p.75-81

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Oncology
(54)
Humans
(40)
Female
(39)
Middle Aged
(27)
Adult
(25)
Breast Cancer
(25)
Aged
(24)
Obstetrics & Gynecology
(23)
Biological And Medical Sciences
(18)
Chemotherapy
(18)
Tumors
(18)
Medical Sciences
(17)
Breast Neoplasms - Drug Therapy
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Breast Neoplasms - Pathology
(13)
Disease-Free Survival
(12)
Paclitaxel - Administration & Dosage
(12)
Treatment Outcome
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(18)
Breast Care
(15)
Geburtshilfe Und Frauenheilkunde
(10)
European Journal Of Cancer
(7)
Jnci : Journal Of The National Cancer Institute
(5)
Cancer
(4)
Annals Of Oncology
(2)
Anticancer Research
(2)
Bmc Cancer
(2)
Breast
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma : N33 and EFA6R have a potential impact on overall survival

Fatal events during clinical trials: an evaluation of deaths during breast cancer studies

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients

Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study

Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial

Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients

Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?

mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease

Phase III postneoadjuvant study evaluating sacituzumab govitecan, an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy

Abstract PD3-04: Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial

Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database

Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52)

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

A matrix of morphology and distribution of calcifications in the breast: Analysis of 849 vacuum-assisted biopsies

Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer

Suchergebnisse filtern